EUVIMEDEUVIMED entdecken
Video/Audio

Circulating Glioma Model for Chimeric Antigen Receptor T-Cell Therapy Investigations

Yuhan Zhang, Shuo Sun, Hongyi Liu, Yun Chen, Xiaoqin Chen

Journal of Visualized Experiments · 2025

DOI: 10.3791/68881 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2025. Verfasst von Yuhan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Southeast University; Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu …. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells in cerebrospinal fluid (CSF) are a significant factor in tumor recurrence and intracranial metastasis in glioma. Many studies are attempting to identify effective strategies to target and eliminate the circulating tumor in CSF. Chimeric antigen receptor (CAR) T-cell therapy has been frequently used for various circulating tumors. However, research is limited due to the lack of a suitable circulating glioma model. Here, a circulating glioma model was developed and applied in CAR T-cell therapy investigations. This model was constructed using the lateral ventricle injection, which is widely used in the local treatment of intracranial disease. The glioma cells were injected into the lateral ventricle to form the intracranial primary tumor. The tumors that were shed from the lateral ventricle were used to indicate the circulating tumor in CSF. The model is easy to build and can be applied in various studies on the CAR T-cell therapy of circulating glioma. As a result, the circulating glioma model provides a unique glioma metastasis model for effective CAR T-cell therapy studies of the circulating tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsReceptors, Chimeric AntigenImmunotherapy, AdoptiveNeoplastic Cells, CirculatingDisease Models, AnimalReceptors, Antigen, T-CellAnimalsHumansMiceT-LymphocytesCell Line, Tumor

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Southeast University; Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University.
  • Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University.
  • Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University.
  • School of Chemistry and Chemical Engineering, Southeast University; Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University; chenyun@njmu.edu.cn.
  • Department of Clinical Laboratory Medicine, Children's Hospital of Nanjing Medical University; 46958557@qq.com.

Zitieren

APA

Zhang, Y., Sun, S., Liu, H., Chen, Y., & Chen, X. (2025). Circulating Glioma Model for Chimeric Antigen Receptor T-Cell Therapy Investigations. Journal of Visualized Experiments. https://doi.org/10.3791/68881

Vancouver

Zhang Y, Sun S, Liu H, Chen Y, Chen X. Circulating Glioma Model for Chimeric Antigen Receptor T-Cell Therapy Investigations. Journal of Visualized Experiments. 2025. doi:10.3791/68881

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuhan and Sun, Shuo and Liu, Hongyi and Chen, Yun and Chen, Xiaoqin},
  title = {Circulating Glioma Model for Chimeric Antigen Receptor T-Cell Therapy Investigations},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/68881}
}
Kostenlos starten →